Dermata Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DRMA and other ETFs, options, and stocks.

About DRMA

Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company that focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin diseases. Its product pipeline includes DMT310, DMT400, and DMT410.

CEO

Gerald T. Proehl

CEOGerald T. Proehl

Employees

Employees8

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2014

Founded2014

Employees

Employees8

DRMA Key Statistics

Market cap

2.27M

Market cap2.27M

Price-Earnings ratio

-0.08

Price-Earnings ratio-0.08

Dividend yield

—

Dividend yield—

Average volume

32.63K

Average volume32.63K

High today

$0.355

High today$0.355

Low today

$0.3304

Low today$0.3304

Open price

$0.3373

Open price$0.3373

Volume

22.01K

Volume22.01K

52 Week high

$3.68

52 Week high$3.68

52 Week low

$0.232

52 Week low$0.232

Dermata Therapeutics

Why Robinhood?

Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company that focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin diseases. Its product pipeline includes DMT310, DMT400, and DMT410. Show more

DRMA Key Statistics

Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company that focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin diseases. Its product pipeline includes DMT310, DMT400, and DMT410.